Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital

Journal of Diabetes Science and Technology

Volumn 7, Issue 1, 2013, Pages 238-246

  Okabayashi, Takehiro ^a   Kozuki, Akihito ^a   Sumiyoshi, Tatsuaki ^a   Shima, Yasuo ^a  

^a Kochi Health Sciences Center   (Japan)

Author keywords

Closed loop glycemic control system; Hypoglycemia; Intensive care unit; Intensive insulin therapy; Liver; Pancreas; STG; Surgery; Tight glycemic control

Indexed keywords

GLUCOSE; INSULIN;

ACCURACY; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD GLUCOSE MONITORING; CANINE MODEL; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE REGULATION SYSTEM; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN PUMP; INSULIN TREATMENT; INTENSIVE CARE UNIT; MALE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NONHUMAN; PANCREAS RESECTION; REVIEW; SYSTEMATIC REVIEW (TOPIC); WORKLOAD; ARTICLE; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; EQUIPMENT; GENETIC PROCEDURES; INSULIN INFUSION; METHODOLOGY; PERIOPERATIVE PERIOD; REPRODUCIBILITY;

AGED; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; CRITICAL ILLNESS; FEMALE; GLUCOSE; HUMANS; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS; INTENSIVE CARE UNITS; MALE; PERIOPERATIVE CARE; REPRODUCIBILITY OF RESULTS;

EID: 84880765015     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700129     Document Type: Review

References (26)

1. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H, Kobayashi M, Hanazaki K. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect. 2009;73(1):47-53.
2. Okabayashi T, Hanazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci. 2008;53(5):1405-10. (Pubitemid 351514618)
3. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.
4. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-44.
5. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
6. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72.
7. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39.
8. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev. 2007;23(3):184-92. (Pubitemid 46437843)
9. Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs. 2012;15(1):71-6.
10. Garrouste-Orgeas M, Timsit JF, Vesin A, Schwebel C, Arnodo P, Lefrant JY, Souweine B, Tabah A, Charpentier J, Gontier O, Fieux F, Mourvillier B, Troché G, Reignier J, Dumay MF, Azoulay E, Reignier B, Carlet J, Soufir L; OUTCOMEREA Study Group. Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II. Am J Respir Crit Care Med. 2010;181(2):134-42.
11. Van den Berghe G. Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia. 2008;51(6):911-5.
12. Tsukamoto Y, Okabayashi T, Hanazaki K. Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery. Surg Today. 2011;41(10):1344-51.
13. Hanazaki K, Nosé Y, Brunicardi FC. Artificial endocrine pancreas. J Am Coll Surg. 2001;193(3):310-22. (Pubitemid 32834768)
14. Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang XP, Nosé Y, Brunicardi FC. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs. 2005;29(1):83-7. (Pubitemid 41602009)
15. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106(1):160-3.
16. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009;53(1):66-71.
17. Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol. 2003;98(10):2293-8.
18. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002;6(1):88-94. (Pubitemid 40433594)
19. Ambiru S, Kato A, Kimura F, Shimizu H, Yoshidome H, Otsuka M, Miyazaki M. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. J Hosp Infect. 2008;68(3):230-3.
20. Blondet JJ, Beilman G. Glycemic control and prevention of perioperative infection. Curr Opin Crit Care. 2007;13(4):421-7. (Pubitemid 47015779)
21. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-61. (Pubitemid 27084552)
22. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352-60.
23. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care. 2009;32(8):1425-7.
24. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, Kohsaki T, Kobayashi M, Hanazaki K. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg. 2009;144(10):933-7.
25. Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest. 2006;116(7):1767-75. (Pubitemid 44033296)
26. Ganda OP. Secondary forms of diabetes. In: Kahn CR, Weir GC, eds. Joslin's diabetes mellitus. 13th ed. Malvern: Lea & Febiger; 1994.